Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
ConclusionsThis study found a 2.4-fold higher than expected rate of SMN —and a slightly increased rate of hypogonadism—in the long-term period following carboplatin treatment. Although further studies are needed to confirm these preliminary findings, these results are probably informative for clinicians caring for seminoma patients.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Hypertension | Infertility | Low Testosterone | Neurology | Peptic Ulcer | Peripheral Neuropathy | Reproduction Medicine | Seminoma | Statistics | Study | Testicular Cancer | Tinnitus